YieldMax MRNA Option Income Strategy ETF (NYSEARCA:MRNY) Sees Large Increase in Short Interest

YieldMax MRNA Option Income Strategy ETF (NYSEARCA:MRNY) was the recipient of a significant growth in short interest in the month of September. As of September 15th, there was short interest totaling 80,671 shares, a growth of 57.3% from the August 31st total of 51,284 shares. Based on an average trading volume of 218,763 shares, the short-interest ratio is presently 0.4 days. Currently, 1.5% of the shares of the company are sold short.

YieldMax MRNA Option Income Strategy ETF Trading Down 3.4%

YieldMax MRNA Option Income Strategy ETF stock traded down $1.35 during trading hours on Thursday, hitting $38.86. The stock had a trading volume of 179,413 shares, compared to its average volume of 243,332. The company has a 50-day moving average of $27.69 and a two-hundred day moving average of $21.07. YieldMax MRNA Option Income Strategy ETF has a fifty-two week low of $13.60 and a fifty-two week high of $42.63.

YieldMax MRNA Option Income Strategy ETF Company Profile

The YieldMax MRNA Option Income Strategy ETF (MRNY) is an exchange-traded fund that mostly invests in health care equity. The fund seeks to provide current income and capped gains on the Moderna stock (MRNA) through a synthetic covered call strategy, collateralized by cash and US Treasurys. The actively managed fund uses both standardized exchange-traded and FLEX options. MRNY was launched on Oct 23, 2023 and is issued by YieldMax.